Searched for
ANTIBODY DRUGS COMBINATION
USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZenecaEvusheld is the first long-acting antibody to receive emergency use authorisation in the US for pre-exposure prophylaxis of COVID-19, in ad...17 Dec, 2021, 03.32 PM IST- China's Brii says its COVID-19 antibody cocktail retains activity against OmicronTest details for the dual-antibody treatment, which last week became the first approved COVID-19 antibody cocktail in China, would not be a...13 Dec, 2021, 10.18 AM IST
- AstraZeneca adds 2.5% after initiating talks on Covid prevention drug with Indian authoritiesEvusheld, a Covid-19 prevention drug for individuals with weakened immune systems, has received emergency use authorisation in the US.10 Dec, 2021, 11.56 AM IST
- US authorizes AstraZeneca Covid-19 treatment in some casesThe FDA warned the drug Evusheld is "not a substitute for vaccination in individuals for whom Covid-19 vaccination is recommended" and can ...09 Dec, 2021, 07.48 AM IST
- Monoclonal antibody treatment combo keeps high-risk Covid patients out of hospital: StudyThe research enrolled nearly 1,400 patients, of whom 696 received the drug combo.31 Aug, 2021, 07.53 PM IST
- Antibody cocktail therapy begins at AIIMS, RishikeshAntibody cocktail is a combination of two drugs and its vial costs nearly Rs 60000 in the market.22 Jun, 2021, 10.50 PM IST
- Doctors call monoclonal antibody cocktail ‘first Covid treatment’The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works ju...03 Jun, 2021, 10.29 AM IST
- Eli Lilly India gets nod for emergency use of antibody drugs combination for COVID-19The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 ...01 Jun, 2021, 06.15 PM IST
- Cipla to market Roche's Antibody Cocktail in IndiaCipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...24 May, 2021, 01.54 PM IST
- AstraZeneca, U.S. agree 500,000 more supplies of COVID-19 antibody cocktailThe antibody therapy, which has yet to be approved by U.S. regulators, is designed to treat the disease rather than prevent it like the vac...16 Mar, 2021, 02.30 PM IST
- GSK to widen COVID-19 antibody treatment trial after safety clearanceThe long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation, typically...06 Oct, 2020, 06.52 PM IST
- Biopharma giant AstraZeneca begins coronavirus dual-use antibody drug trial in UKThe drug known as AZD7442 has the potential to be given as a preventative option for people exposed to the coronavirus, and to treat and pr...25 Aug, 2020, 04.48 PM IST
- Covid-19: A cure still elusive, but science may find a wayIndia continues to see new cases and is one of the few countries to witness a rise after substantially relaxing lockdown restrictions. Scie...13 Jun, 2020, 07.24 AM IST
- Scientists create antibody that claims to defeat coronavirus in labMore research is needed to see whether the findings are confirmed in a clinical setting and how precisely the antibody defeats the virus.06 May, 2020, 05.32 PM IST
- Potential trigger to kill cancer discoveredScientists, including one of Indian-origin, have discovered a new way of triggering cell death. This may lead to drugs for treating cancer.28 May, 2016, 11.55 AM IST
- Rabishield: First fast-acting anti-rabies drug set for India launchRMAb has been developed by Pune-based Serum Institute of India (SII) and US-based Mass Biologics of the University of Massachusetts Medical...24 Feb, 2016, 12.51 PM IST
- Biocon to partner US-based firm for developing cancer drugBiotech major Biocon Ltd on Thursday said it will enter into a partnership with a US-based biotechnology company, Iatrica, to develop drug ...17 Jan, 2008, 02.46 PM IST
Load More
